Free and total prostate-specific antigen serum concentrations do not help to detect prostate cancer in patients with urinary outlet obstruction

British Journal of Urology

Volumn 80, Issue 4, 1997, Pages 618-622

  Trygg, G ^a,b,d   Pousette, A ^a,b,c   Ekengren, J ^a,b,c,d   Hahn, R G ^a,b,c,d  

^a Department of Molecular Medicine and Surgery   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Sabbatsberg Hospital   (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Mortality; Prostate specific antigen; Prostatic hypertrophy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CANCER DIAGNOSIS; CANCER GROWTH; CAUSE OF DEATH; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TRANSURETHRAL RESECTION;

EID: 0031400549     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00423.x     Document Type: Article

References (8)

1. Woolf SH. Screening for prostate cancer with prostate-specific antigen. N Engl J Med 1995; 333: 1401-5
2. Fosså SD, Paus E. Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. Eur Urol 1994; 26: 29-34
3. Evans CP, Gaendrian V, Tewari A et al. The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate. Br J Urol 1996; 78: 426-31
4. Christensson A, Björk T, Nilsson O et al. Serum prostate specific antigen complexed to α-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-5
5. Oesterling JE, Jacobsen SJ, Klee GG et al. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for the concentrations and ratios. J Urol 1995; 154: 1090-5
6. Wolff JM, Borchers H, Effert PJ, Habib FK, Jakse GJ. Free-to-total prostate-specific antigen serum concentrations in patients with prostatic cancer and benign prostatic hyperplasia. Br J Urol 1996; 78: 409-13
7. Ekengren J, Hahn RG. Blood loss during transurethral resection of the prostate as measured with the HemoCue photometer. Scand J Urol Nephrol 1993; 27: 501-7
8. Aus G, Hugosson J, Norlén L. Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 1995; 154: 460-5